Related Experiment Video

Updated: May 15, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

798

SIRT5-mediated BCAT1 desuccinylation and stabilization leads to ferroptosis insensitivity and promotes cell

Tao Wang1, Xin-Hao Han2, Jun-Jun Chen2

  • 1Institute of Geriatrics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China. wangtaoalepellis@gmail.com.

Cell Death & Disease
|April 8, 2025
PubMed

Insights

Sirtuin 5 (SIRT5) promotes glioma growth by regulating branched-chain amino acid metabolism and inhibiting ferroptosis. Targeting SIRT5 may offer a new therapeutic strategy for aggressive brain tumors.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Glioma is an aggressive brain tumor with poor treatment outcomes.
  • Sirtuin 5 (SIRT5) has a complex role in cancer, acting as a potential therapeutic target.
  • Understanding SIRT5's function in glioma is crucial for developing new treatments.

Purpose of the Study:

  • To investigate the role and underlying mechanisms of SIRT5 in glioma progression.
  • To explore the relationship between SIRT5, branched-chain amino acid (BCAA) metabolism, and ferroptosis in glioma.
  • To assess the clinical relevance of SIRT5 and its associated pathways in glioma patients.

Main Methods:

  • In vitro and in vivo glioma cell models were used to study SIRT5 function.
  • Proteomic and metabolomic analyses identified key downstream pathways.
  • Biochemical assays examined the interaction between SIRT5, BCAT1, and CHIP.
  • Clinical glioma samples were analyzed for SIRT5 and BCAT1 expression.

Main Results:

  • SIRT5 expression is upregulated in glioma cells.
  • SIRT5 knockdown inhibited glioma cell proliferation and increased ferroptosis sensitivity.
  • SIRT5 regulates BCAT1 stability via desuccinylation, impacting BCAA metabolism.
  • Overexpression of BCAT1 rescued the effects of SIRT5 knockdown.
  • Elevated SIRT5 and BCAT1 levels correlate with advanced glioma grade and poor prognosis.

Conclusions:

  • SIRT5 promotes glioma progression by enhancing BCAA metabolism and conferring resistance to ferroptosis.
  • SIRT5 acts through the desuccinylation and stabilization of BCAT1.
  • SIRT5 and BCAT1 represent potential therapeutic targets for glioma treatment.

More Related Videos

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.4K
Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

8.2K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K